The role of natural Siberian fir terpenoids in the prevention of dyslipidemia in patients with type 2 diabetes

• Evgeniya М. Bibova

Abstract

The article provides a review of domestic and foreign literature on the role of natural terpenoids in the correction of dyslipidemia in patients with type 2 diabetes. Discusses the causes and complications development of type 2 diabetes in the form of dyslipidemia from the point of view of scientific approach and to improve the effectiveness of the prevention and treatment of atherosclerosis with simultaneous correction of the metabolic syndrome.

Keywords:dyslipidemia, type 2 diabetes mellitus, atherosclerosis, metabolic syndrome, natural terpenoids

References

1. Aleksandrov A.A. Coronary artery disease and diabetes. Moscow: ENTs RAMN, 2004: 36 p. (in Russian)

2. Aleksandrov A.A. Diabetes mellitus: the disease of «exploding» plaques. Consilium Medicum. 2001; l (10): 464-5. (in Russian)

3. Ametov A.S., Demidova T. Yu. Principles of therapy for type 2 diabetes in combination with arterial hypertension: Training guide. Moscow, 2001: 14-5. (in Russian)

4. WHO. Health issue. URL: //https://www.who.int/ru/news-room/fact-sheets/detail/diabetes

5. IDF Diabetes Atlas. 7th ed. 2015. URL: http://www.diabetesatlas.org/resources/2015-atlas.html

6. Algorithms for specialized medical care for patients with diabetes. 7th issue. In: I.I. Dedov, M.V. Shestakova (eds). Moscow, 2015: 111 p. (in Russian)

7. Mokhort T.V. Dyslipidemia and diabetes: new data. Meditsinskie novosti [Medical News]. 2012; (9): 49-55. (in Russian)

8. Emerging Risk Factors Collaboration. Diabetes mellitus, fasting blood glucose concentration, and risk vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet. 2010; 375 (9733): 2215-22.

9. Ford E.S., Zhao G., Li C. Pre-diabetes and the risk for cardiovascular disease: a systematic review of the evidence. J Am Coll Cardiol. 2010; 55 (13): 1307-10.

10. Seshasai S.R., Kaptoge S., Thompson A., et al.; Emerging Risk Factors Collaboration. Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med. 2011; 364 (9): 829-41.

11. Turner R.C., Millns H., Neil H.A., et al. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23). BMJ. 1998; 316 (7134): 823-8.

12. Doskina E.V., Maganova F.I., Zotova E.M. Role of natural terpenoids in early prevention of atherosclerosis and metabolic syndrome (literature review). Dnevnik kazanskoy meditsinskoy shkoly [Diary of the Kazan Medical School]. 2019; (4): 137-41. (in Russian)

13. Pentegova V.A., Dubovenko Zh.V., Raldugin V.A., Shmidt E.P. Terpenoids of coniferous plants. Novosibirsk: Nauka, 1987: 97 p. (in Russian)

14. Makarchuk N.M., Leshchinskaya Ya.S., Akimov Yu.A., et al. Phytoncides in medicine. Kiev: Naukova Dumka, 1990: 216 p. (in Russian)

15. Mashkovskiy M.D. Medicines: a guide for doctors. 16th ed., revised and additional. Moscow: Novaya Volna, 2016: 1216 p. (in Russian)

16. Latserus L.A., Pinigin A.F., Pinigina N.M., Maganova F.I., Makarov V.G. Terpenoid agent for the prevention and treatment of atherosclerosis and correction of metabolic syndrome. WO 2013/176564 A1 of 28.11.2013; RST/RU 2012/00042. (in Russian).

17. Yakushin S.S., Filippov E.V., Petrov V.S. Modern approaches to the treatment of dyslipidemias in clinical practice. Meditsinskiy sovet [Medical Council]. 2017; (3): 48-53. (in Russian)

18. Urazgil'deyeva S.A., Malygina O.F. Features of treatment of dyslipidemia in patients with type 2 diabetes. Meditsinskiy sovet [Medical Council]. 2016; (3): 48-53. (in Russian)

All articles in our journal are distributed under the Creative Commons Attribution 4.0 International License (CC BY 4.0 license)